PubMed:19136585
Annnotations
Glycan-Motif
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 134-151 | https://glytoucan.org/Structures/Glycans/G20420WT | denotes | lactosylceramides |
| T2 | 134-151 | https://glytoucan.org/Structures/Glycans/G74621DY | denotes | lactosylceramides |
| T3 | 134-151 | https://glytoucan.org/Structures/Glycans/G84224TW | denotes | lactosylceramides |
| T4 | 440-447 | https://glytoucan.org/Structures/Glycans/G00047MO | denotes | Lewis A |
| T5 | 452-466 | https://glytoucan.org/Structures/Glycans/G00053MO | denotes | sialyl Lewis A |
| T6 | 1787-1804 | https://glytoucan.org/Structures/Glycans/G20420WT | denotes | lactosylceramides |
| T7 | 1787-1804 | https://glytoucan.org/Structures/Glycans/G74621DY | denotes | lactosylceramides |
| T8 | 1787-1804 | https://glytoucan.org/Structures/Glycans/G84224TW | denotes | lactosylceramides |
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 134-151 | Glycan_Motif | denotes | lactosylceramides | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G74621DY|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G20420WT |
| T4 | 440-447 | Glycan_Motif | denotes | Lewis A | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G39023AU|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00047MO |
| T6 | 452-466 | Glycan_Motif | denotes | sialyl Lewis A | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G81971FM|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G00053MO |
| T8 | 1787-1804 | Glycan_Motif | denotes | lactosylceramides | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G84224TW|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G74621DY|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G20420WT |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 134-151 | https://glytoucan.org/Structures/Glycans/G20420WT | denotes | lactosylceramides |
| T2 | 134-151 | https://glytoucan.org/Structures/Glycans/G74621DY | denotes | lactosylceramides |
| T3 | 134-151 | https://glytoucan.org/Structures/Glycans/G84224TW | denotes | lactosylceramides |
| T4 | 440-447 | https://glytoucan.org/Structures/Glycans/G00047MO | denotes | Lewis A |
| T5 | 452-466 | https://glytoucan.org/Structures/Glycans/G00053MO | denotes | sialyl Lewis A |
| T6 | 459-466 | https://glytoucan.org/Structures/Glycans/G00047MO | denotes | Lewis A |
| T7 | 1787-1804 | https://glytoucan.org/Structures/Glycans/G20420WT | denotes | lactosylceramides |
| T8 | 1787-1804 | https://glytoucan.org/Structures/Glycans/G74621DY | denotes | lactosylceramides |
| T9 | 1787-1804 | https://glytoucan.org/Structures/Glycans/G84224TW | denotes | lactosylceramides |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 170-177 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colonic |
| T2 | 1203-1210 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colonic |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-199 | Sentence | denotes | Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines. |
| TextSentencer_T2 | 200-542 | Sentence | denotes | In general, an elevated expression of beta 3-galactosyltransferase (beta 3GalT) activity contributed by beta 3GalT5 correlates well with increased biosynthesis and expression of type 1 chain (Gal beta 1-3GlcNAc beta 1-) derivatives such as Lewis A and sialyl Lewis A, which are mostly recognized as terminal epitopes and not further extended. |
| TextSentencer_T3 | 543-796 | Sentence | denotes | Most known beta 3-N-acetylglucosaminyltransferases show a higher activity toward extending type 2 chain (Gal beta 1-4GlcNAc beta 1-), and an over-expression of beta 3GalT5 could suppress the formation of the type 2 chain poly-N-acetyllactosaminoglycans. |
| TextSentencer_T4 | 797-1029 | Sentence | denotes | The potential of extending instead the predominant type 1 chain termini synthesized under such circumstances was, however, not investigated, partly due to technical difficulty in unambiguous identification of extended type 1 chains. |
| TextSentencer_T5 | 1030-1472 | Sentence | denotes | Using an advanced mass spectrometry-based glycomic mapping and glycan sequencing approach, we show here that type 1 chains carried on the lacto-series glycosphingolipids of colonic carcinoma cells can be extended when the endogenous beta 3GalT activity relative to competing beta 4GalT activity, as defined against a common GlcNAc beta 1-3Gal beta 1-4Glc acceptor, is sufficiently high, as found in Colo205 and SW1116, but not in DLD-1 cells. |
| TextSentencer_T6 | 1473-1805 | Sentence | denotes | In support of this positive correlation, the lacto-series glycosphingolipids isolated from stably transfected DLD-1 clones over-expressing beta 3GalT5 were shown to comprise fucosylated dimeric type 1 chains, whereas a mock transfectant and the DLD-1 parent carried only fucosylated dimeric type 2 chains on their lactosylceramides. |
| TextSentencer_T7 | 1806-2227 | Sentence | denotes | It suggests that while the natural expression of extended type 1 chain is likely to be determined by many contributing factors including the relative amounts of competing glycosyltransferases and the UDP-Gal level, the enhanced expression of beta 3GalT5 is sufficient to promote in vivo extension of type 1 chains by furnishing a significantly higher amount of type 1 chain precursors relative to competing type 2 chains. |
| T1 | 0-199 | Sentence | denotes | Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines. |
| T2 | 200-542 | Sentence | denotes | In general, an elevated expression of beta 3-galactosyltransferase (beta 3GalT) activity contributed by beta 3GalT5 correlates well with increased biosynthesis and expression of type 1 chain (Gal beta 1-3GlcNAc beta 1-) derivatives such as Lewis A and sialyl Lewis A, which are mostly recognized as terminal epitopes and not further extended. |
| T3 | 543-796 | Sentence | denotes | Most known beta 3-N-acetylglucosaminyltransferases show a higher activity toward extending type 2 chain (Gal beta 1-4GlcNAc beta 1-), and an over-expression of beta 3GalT5 could suppress the formation of the type 2 chain poly-N-acetyllactosaminoglycans. |
| T4 | 797-1029 | Sentence | denotes | The potential of extending instead the predominant type 1 chain termini synthesized under such circumstances was, however, not investigated, partly due to technical difficulty in unambiguous identification of extended type 1 chains. |
| T5 | 1030-1472 | Sentence | denotes | Using an advanced mass spectrometry-based glycomic mapping and glycan sequencing approach, we show here that type 1 chains carried on the lacto-series glycosphingolipids of colonic carcinoma cells can be extended when the endogenous beta 3GalT activity relative to competing beta 4GalT activity, as defined against a common GlcNAc beta 1-3Gal beta 1-4Glc acceptor, is sufficiently high, as found in Colo205 and SW1116, but not in DLD-1 cells. |
| T6 | 1473-1805 | Sentence | denotes | In support of this positive correlation, the lacto-series glycosphingolipids isolated from stably transfected DLD-1 clones over-expressing beta 3GalT5 were shown to comprise fucosylated dimeric type 1 chains, whereas a mock transfectant and the DLD-1 parent carried only fucosylated dimeric type 2 chains on their lactosylceramides. |
| T7 | 1806-2227 | Sentence | denotes | It suggests that while the natural expression of extended type 1 chain is likely to be determined by many contributing factors including the relative amounts of competing glycosyltransferases and the UDP-Gal level, the enhanced expression of beta 3GalT5 is sufficient to promote in vivo extension of type 1 chains by furnishing a significantly higher amount of type 1 chain precursors relative to competing type 2 chains. |
| T1 | 0-199 | Sentence | denotes | Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines. |
| T2 | 200-542 | Sentence | denotes | In general, an elevated expression of beta 3-galactosyltransferase (beta 3GalT) activity contributed by beta 3GalT5 correlates well with increased biosynthesis and expression of type 1 chain (Gal beta 1-3GlcNAc beta 1-) derivatives such as Lewis A and sialyl Lewis A, which are mostly recognized as terminal epitopes and not further extended. |
| T3 | 543-796 | Sentence | denotes | Most known beta 3-N-acetylglucosaminyltransferases show a higher activity toward extending type 2 chain (Gal beta 1-4GlcNAc beta 1-), and an over-expression of beta 3GalT5 could suppress the formation of the type 2 chain poly-N-acetyllactosaminoglycans. |
| T4 | 797-1029 | Sentence | denotes | The potential of extending instead the predominant type 1 chain termini synthesized under such circumstances was, however, not investigated, partly due to technical difficulty in unambiguous identification of extended type 1 chains. |
| T5 | 1030-1472 | Sentence | denotes | Using an advanced mass spectrometry-based glycomic mapping and glycan sequencing approach, we show here that type 1 chains carried on the lacto-series glycosphingolipids of colonic carcinoma cells can be extended when the endogenous beta 3GalT activity relative to competing beta 4GalT activity, as defined against a common GlcNAc beta 1-3Gal beta 1-4Glc acceptor, is sufficiently high, as found in Colo205 and SW1116, but not in DLD-1 cells. |
| T6 | 1473-1805 | Sentence | denotes | In support of this positive correlation, the lacto-series glycosphingolipids isolated from stably transfected DLD-1 clones over-expressing beta 3GalT5 were shown to comprise fucosylated dimeric type 1 chains, whereas a mock transfectant and the DLD-1 parent carried only fucosylated dimeric type 2 chains on their lactosylceramides. |
| T7 | 1806-2227 | Sentence | denotes | It suggests that while the natural expression of extended type 1 chain is likely to be determined by many contributing factors including the relative amounts of competing glycosyltransferases and the UDP-Gal level, the enhanced expression of beta 3GalT5 is sufficient to promote in vivo extension of type 1 chains by furnishing a significantly higher amount of type 1 chain precursors relative to competing type 2 chains. |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 134-151 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | lactosylceramides |
| T2 | 440-447 | http://www.glycoepitope.jp/epitopes/EP0007 | denotes | Lewis A |
| T3 | 452-466 | http://www.glycoepitope.jp/epitopes/EP0008 | denotes | sialyl Lewis A |
| T4 | 1787-1804 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | lactosylceramides |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 23-53 | gene:10317 | denotes | beta 3-galactosyltransferase 5 |
| T1 | 170-187 | disease:C0699790 | denotes | colonic carcinoma |
| R1 | T0 | T1 | associated_with | beta 3-galactosyltransferase 5,colonic carcinoma |
GlycoBiology-FMA
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| _T1 | 134-151 | FMAID:82821 | denotes | lactosylceramides |
| _T2 | 134-151 | FMAID:196817 | denotes | lactosylceramides |
| _T3 | 170-177 | FMAID:104231 | denotes | colonic |
| _T4 | 170-177 | FMAID:14543 | denotes | colonic |
| _T5 | 1081-1088 | FMAID:90078 | denotes | mapping |
| _T6 | 1181-1199 | FMAID:196810 | denotes | glycosphingolipids |
| _T7 | 1181-1199 | FMAID:82817 | denotes | glycosphingolipids |
| _T8 | 1181-1199 | FMAID:196812 | denotes | glycosphingolipids |
| _T9 | 1181-1199 | FMAID:196807 | denotes | glycosphingolipids |
| _T10 | 1181-1199 | FMAID:82813 | denotes | glycosphingolipids |
| _T11 | 1181-1199 | FMAID:82812 | denotes | glycosphingolipids |
| _T12 | 1181-1199 | FMAID:196814 | denotes | glycosphingolipids |
| _T13 | 1181-1199 | FMAID:196806 | denotes | glycosphingolipids |
| _T14 | 1181-1199 | FMAID:82811 | denotes | glycosphingolipids |
| _T15 | 1181-1199 | FMAID:82814 | denotes | glycosphingolipids |
| _T16 | 1181-1199 | FMAID:82818 | denotes | glycosphingolipids |
| _T17 | 1181-1199 | FMAID:196808 | denotes | glycosphingolipids |
| _T18 | 1181-1199 | FMAID:82815 | denotes | glycosphingolipids |
| _T19 | 1181-1199 | FMAID:196815 | denotes | glycosphingolipids |
| _T20 | 1181-1199 | FMAID:82819 | denotes | glycosphingolipids |
| _T21 | 1181-1199 | FMAID:196809 | denotes | glycosphingolipids |
| _T22 | 1181-1199 | FMAID:196813 | denotes | glycosphingolipids |
| _T23 | 1203-1210 | FMAID:104231 | denotes | colonic |
| _T24 | 1203-1210 | FMAID:14543 | denotes | colonic |
| _T25 | 1221-1226 | FMAID:68646 | denotes | cells |
| _T26 | 1221-1226 | FMAID:169002 | denotes | cells |
| _T27 | 1466-1471 | FMAID:169002 | denotes | cells |
| _T28 | 1466-1471 | FMAID:68646 | denotes | cells |
| _T29 | 1531-1549 | FMAID:82814 | denotes | glycosphingolipids |
| _T30 | 1531-1549 | FMAID:82817 | denotes | glycosphingolipids |
| _T31 | 1531-1549 | FMAID:82812 | denotes | glycosphingolipids |
| _T32 | 1531-1549 | FMAID:196807 | denotes | glycosphingolipids |
| _T33 | 1531-1549 | FMAID:196812 | denotes | glycosphingolipids |
| _T34 | 1531-1549 | FMAID:196809 | denotes | glycosphingolipids |
| _T35 | 1531-1549 | FMAID:196808 | denotes | glycosphingolipids |
| _T36 | 1531-1549 | FMAID:82819 | denotes | glycosphingolipids |
| _T37 | 1531-1549 | FMAID:196814 | denotes | glycosphingolipids |
| _T38 | 1531-1549 | FMAID:82813 | denotes | glycosphingolipids |
| _T39 | 1531-1549 | FMAID:82815 | denotes | glycosphingolipids |
| _T40 | 1531-1549 | FMAID:82811 | denotes | glycosphingolipids |
| _T41 | 1531-1549 | FMAID:196806 | denotes | glycosphingolipids |
| _T42 | 1531-1549 | FMAID:82818 | denotes | glycosphingolipids |
| _T43 | 1531-1549 | FMAID:196813 | denotes | glycosphingolipids |
| _T44 | 1531-1549 | FMAID:196810 | denotes | glycosphingolipids |
| _T45 | 1531-1549 | FMAID:196815 | denotes | glycosphingolipids |
| _T46 | 1787-1804 | FMAID:196817 | denotes | lactosylceramides |
| _T47 | 1787-1804 | FMAID:82821 | denotes | lactosylceramides |
uniprot-human
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 23-51 | http://www.uniprot.org/uniprot/O75752 | denotes | beta 3-galactosyltransferase |
| T2 | 238-266 | http://www.uniprot.org/uniprot/O75752 | denotes | beta 3-galactosyltransferase |
| T3 | 23-51 | http://www.uniprot.org/uniprot/O60512 | denotes | beta 3-galactosyltransferase |
| T4 | 238-266 | http://www.uniprot.org/uniprot/O60512 | denotes | beta 3-galactosyltransferase |
| T5 | 396-402 | http://www.uniprot.org/uniprot/Q92988 | denotes | beta 1 |
| T6 | 411-417 | http://www.uniprot.org/uniprot/Q92988 | denotes | beta 1 |
| T7 | 652-658 | http://www.uniprot.org/uniprot/Q92988 | denotes | beta 1 |
| T8 | 667-673 | http://www.uniprot.org/uniprot/Q92988 | denotes | beta 1 |
| T9 | 1361-1367 | http://www.uniprot.org/uniprot/Q92988 | denotes | beta 1 |
| T10 | 1373-1379 | http://www.uniprot.org/uniprot/Q92988 | denotes | beta 1 |
| T11 | 561-593 | http://www.uniprot.org/uniprot/Q06430 | denotes | N-acetylglucosaminyltransferases |
| T12 | 561-593 | http://www.uniprot.org/uniprot/Q8N0V5 | denotes | N-acetylglucosaminyltransferases |
| T13 | 561-593 | http://www.uniprot.org/uniprot/Q8NFS9 | denotes | N-acetylglucosaminyltransferases |
| T14 | 1460-1463 | http://www.uniprot.org/uniprot/Q86WU2 | denotes | DLD |
| T15 | 1583-1586 | http://www.uniprot.org/uniprot/Q86WU2 | denotes | DLD |
| T16 | 1718-1721 | http://www.uniprot.org/uniprot/Q86WU2 | denotes | DLD |
| T17 | 1460-1463 | http://www.uniprot.org/uniprot/P09622 | denotes | DLD |
| T18 | 1583-1586 | http://www.uniprot.org/uniprot/P09622 | denotes | DLD |
| T19 | 1718-1721 | http://www.uniprot.org/uniprot/P09622 | denotes | DLD |
uniprot-mouse
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 30-51 | http://www.uniprot.org/uniprot/P23336 | denotes | galactosyltransferase |
| T2 | 245-266 | http://www.uniprot.org/uniprot/P23336 | denotes | galactosyltransferase |
| T3 | 561-593 | http://www.uniprot.org/uniprot/P97402 | denotes | N-acetylglucosaminyltransferases |
| T4 | 1460-1463 | http://www.uniprot.org/uniprot/Q7TNG8 | denotes | DLD |
| T5 | 1583-1586 | http://www.uniprot.org/uniprot/Q7TNG8 | denotes | DLD |
| T6 | 1718-1721 | http://www.uniprot.org/uniprot/Q7TNG8 | denotes | DLD |
GlycoBiology-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 23-27 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T2 | 23-27 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T3 | 178-187 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
| T4 | 238-242 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T5 | 238-242 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T6 | 268-272 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T7 | 268-272 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T8 | 304-308 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T9 | 304-308 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T10 | 396-400 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T11 | 396-400 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T12 | 411-415 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T13 | 411-415 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T14 | 554-558 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T15 | 554-558 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T16 | 652-656 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T17 | 652-656 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T18 | 667-671 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T19 | 667-671 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T20 | 703-707 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T21 | 703-707 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T22 | 1211-1220 | http://purl.bioontology.org/ontology/NCBITAXON/166034 | denotes | carcinoma |
| T23 | 1221-1226 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T24 | 1263-1267 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T25 | 1263-1267 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T26 | 1305-1309 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T27 | 1305-1309 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T28 | 1361-1365 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T29 | 1361-1365 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T30 | 1373-1377 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T31 | 1373-1377 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T32 | 1466-1471 | http://purl.bioontology.org/ontology/STY/T025 | denotes | cells |
| T33 | 1612-1616 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
| T34 | 1612-1616 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T35 | 1907-1911 | http://purl.bioontology.org/ontology/NCBITAXON/9973 | denotes | many |
| T36 | 2048-2052 | http://purl.bioontology.org/ontology/NCBITAXON/158455 | denotes | beta |
| T37 | 2048-2052 | http://purl.bioontology.org/ontology/NCBITAXON/3554 | denotes | beta |
GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 95-104 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | synthesis |
| T2 | 347-359 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | biosynthesis |
| T3 | 452-458 | http://purl.obolibrary.org/obo/GO_0097503 | denotes | sialyl |
| T4 | 734-743 | http://purl.obolibrary.org/obo/GO_0009058 | denotes | formation |
| T5 | 1647-1658 | http://purl.obolibrary.org/obo/GO_0036065 | denotes | fucosylated |
| T6 | 1744-1755 | http://purl.obolibrary.org/obo/GO_0036065 | denotes | fucosylated |
GO-CC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 188-192 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T2 | 1221-1226 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
| T3 | 1466-1471 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cells |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 170-177 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colonic |
| T2 | 1203-1210 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colonic |
| T3 | 2093-2102 | http://purl.obolibrary.org/obo/UBERON_2000106 | denotes | extension |
NGLY1-deficiency
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-NGLY1-deficiency-B_T1 | 1354-1360 | chem:24139 | denotes | GlcNAc |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 19136585-0#23#53#gene10317 | 23-53 | gene10317 | denotes | beta 3-galactosyltransferase 5 |
| 19136585-0#170#187#diseaseC0699790 | 170-187 | diseaseC0699790 | denotes | colonic carcinoma |
| 19136585-4#430#433#gene1738 | 1460-1463 | gene1738 | denotes | DLD |
| 19136585-4#173#190#diseaseC0699790 | 1203-1220 | diseaseC0699790 | denotes | colonic carcinoma |
| 23#53#gene10317170#187#diseaseC0699790 | 19136585-0#23#53#gene10317 | 19136585-0#170#187#diseaseC0699790 | associated_with | beta 3-galactosyltransferase 5,colonic carcinoma |
| 430#433#gene1738173#190#diseaseC0699790 | 19136585-4#430#433#gene1738 | 19136585-4#173#190#diseaseC0699790 | associated_with | DLD,colonic carcinoma |
GlycoBiology-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 170-177 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colonic |
| T2 | 1203-1210 | http://purl.obolibrary.org/obo/MAT_0000526 | denotes | colonic |
GlycoBiology-Motifs
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 440-445 | http://rdf.glycoinfo.org/glycan/G00047MO | denotes | Lewis |
| T2 | 459-464 | http://rdf.glycoinfo.org/glycan/G00047MO | denotes | Lewis |
| T3 | 452-464 | http://rdf.glycoinfo.org/glycan/G00053MO | denotes | sialyl Lewis |
GlycoBiology-Epitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-GlycoEpitope-B_T1 | 134-151 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | lactosylceramides |
| PD-GlycoEpitope-B_T2 | 1787-1804 | http://www.glycoepitope.jp/epitopes/EP0078 | denotes | lactosylceramides |
| PD-GlycoEpitope-B_T3 | 452-466 | http://www.glycoepitope.jp/epitopes/EP0008 | denotes | sialyl Lewis A |
| PD-GlycoEpitope-B_T4 | 440-447 | http://www.glycoepitope.jp/epitopes/EP0007 | denotes | Lewis A |
| PD-GlycoEpitope-B_T5 | 459-466 | http://www.glycoepitope.jp/epitopes/EP0007 | denotes | Lewis A |
GlyTouCan-IUPAC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| GlycanIUPAC_T1 | 392-395 | "http://rdf.glycoinfo.org/glycan/G93924TT" | denotes | Gal |
| GlycanIUPAC_T2 | 648-651 | "http://rdf.glycoinfo.org/glycan/G93924TT" | denotes | Gal |
| GlycanIUPAC_T3 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G93924TT" | denotes | Gal |
| GlycanIUPAC_T4 | 392-395 | "http://rdf.glycoinfo.org/glycan/G25565DN" | denotes | Gal |
| GlycanIUPAC_T5 | 648-651 | "http://rdf.glycoinfo.org/glycan/G25565DN" | denotes | Gal |
| GlycanIUPAC_T6 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G25565DN" | denotes | Gal |
| GlycanIUPAC_T7 | 392-395 | "http://rdf.glycoinfo.org/glycan/G97215EV" | denotes | Gal |
| GlycanIUPAC_T8 | 648-651 | "http://rdf.glycoinfo.org/glycan/G97215EV" | denotes | Gal |
| GlycanIUPAC_T9 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G97215EV" | denotes | Gal |
| GlycanIUPAC_T10 | 392-395 | "http://rdf.glycoinfo.org/glycan/G79664KO" | denotes | Gal |
| GlycanIUPAC_T11 | 648-651 | "http://rdf.glycoinfo.org/glycan/G79664KO" | denotes | Gal |
| GlycanIUPAC_T12 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G79664KO" | denotes | Gal |
| GlycanIUPAC_T13 | 392-395 | "http://rdf.glycoinfo.org/glycan/G24107FU" | denotes | Gal |
| GlycanIUPAC_T14 | 648-651 | "http://rdf.glycoinfo.org/glycan/G24107FU" | denotes | Gal |
| GlycanIUPAC_T15 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G24107FU" | denotes | Gal |
| GlycanIUPAC_T16 | 392-395 | "http://rdf.glycoinfo.org/glycan/G09864UE" | denotes | Gal |
| GlycanIUPAC_T17 | 648-651 | "http://rdf.glycoinfo.org/glycan/G09864UE" | denotes | Gal |
| GlycanIUPAC_T18 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G09864UE" | denotes | Gal |
| GlycanIUPAC_T19 | 392-395 | "http://rdf.glycoinfo.org/glycan/G28032MC" | denotes | Gal |
| GlycanIUPAC_T20 | 648-651 | "http://rdf.glycoinfo.org/glycan/G28032MC" | denotes | Gal |
| GlycanIUPAC_T21 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G28032MC" | denotes | Gal |
| GlycanIUPAC_T22 | 392-395 | "http://rdf.glycoinfo.org/glycan/G28005UP" | denotes | Gal |
| GlycanIUPAC_T23 | 648-651 | "http://rdf.glycoinfo.org/glycan/G28005UP" | denotes | Gal |
| GlycanIUPAC_T24 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G28005UP" | denotes | Gal |
| GlycanIUPAC_T25 | 392-395 | "http://rdf.glycoinfo.org/glycan/G92708AT" | denotes | Gal |
| GlycanIUPAC_T26 | 648-651 | "http://rdf.glycoinfo.org/glycan/G92708AT" | denotes | Gal |
| GlycanIUPAC_T27 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G92708AT" | denotes | Gal |
| GlycanIUPAC_T28 | 392-395 | "http://rdf.glycoinfo.org/glycan/G73757UC" | denotes | Gal |
| GlycanIUPAC_T29 | 648-651 | "http://rdf.glycoinfo.org/glycan/G73757UC" | denotes | Gal |
| GlycanIUPAC_T30 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G73757UC" | denotes | Gal |
| GlycanIUPAC_T31 | 392-395 | "http://rdf.glycoinfo.org/glycan/G51062DM" | denotes | Gal |
| GlycanIUPAC_T32 | 648-651 | "http://rdf.glycoinfo.org/glycan/G51062DM" | denotes | Gal |
| GlycanIUPAC_T33 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G51062DM" | denotes | Gal |
| GlycanIUPAC_T34 | 392-395 | "http://rdf.glycoinfo.org/glycan/G05866BJ" | denotes | Gal |
| GlycanIUPAC_T35 | 648-651 | "http://rdf.glycoinfo.org/glycan/G05866BJ" | denotes | Gal |
| GlycanIUPAC_T36 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G05866BJ" | denotes | Gal |
| GlycanIUPAC_T37 | 392-395 | "http://rdf.glycoinfo.org/glycan/G87394FZ" | denotes | Gal |
| GlycanIUPAC_T38 | 648-651 | "http://rdf.glycoinfo.org/glycan/G87394FZ" | denotes | Gal |
| GlycanIUPAC_T39 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G87394FZ" | denotes | Gal |
| GlycanIUPAC_T40 | 392-395 | "http://rdf.glycoinfo.org/glycan/G03871NF" | denotes | Gal |
| GlycanIUPAC_T41 | 648-651 | "http://rdf.glycoinfo.org/glycan/G03871NF" | denotes | Gal |
| GlycanIUPAC_T42 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G03871NF" | denotes | Gal |
| GlycanIUPAC_T43 | 392-395 | "http://rdf.glycoinfo.org/glycan/G29377VE" | denotes | Gal |
| GlycanIUPAC_T44 | 648-651 | "http://rdf.glycoinfo.org/glycan/G29377VE" | denotes | Gal |
| GlycanIUPAC_T45 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G29377VE" | denotes | Gal |
| GlycanIUPAC_T46 | 392-395 | "http://rdf.glycoinfo.org/glycan/G33457CX" | denotes | Gal |
| GlycanIUPAC_T47 | 648-651 | "http://rdf.glycoinfo.org/glycan/G33457CX" | denotes | Gal |
| GlycanIUPAC_T48 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G33457CX" | denotes | Gal |
| GlycanIUPAC_T49 | 392-395 | "http://rdf.glycoinfo.org/glycan/G97368GU" | denotes | Gal |
| GlycanIUPAC_T50 | 648-651 | "http://rdf.glycoinfo.org/glycan/G97368GU" | denotes | Gal |
| GlycanIUPAC_T51 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G97368GU" | denotes | Gal |
| GlycanIUPAC_T52 | 392-395 | "http://rdf.glycoinfo.org/glycan/G18512EL" | denotes | Gal |
| GlycanIUPAC_T53 | 648-651 | "http://rdf.glycoinfo.org/glycan/G18512EL" | denotes | Gal |
| GlycanIUPAC_T54 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G18512EL" | denotes | Gal |
| GlycanIUPAC_T55 | 392-395 | "http://rdf.glycoinfo.org/glycan/G41137VS" | denotes | Gal |
| GlycanIUPAC_T56 | 648-651 | "http://rdf.glycoinfo.org/glycan/G41137VS" | denotes | Gal |
| GlycanIUPAC_T57 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G41137VS" | denotes | Gal |
| GlycanIUPAC_T58 | 392-395 | "http://rdf.glycoinfo.org/glycan/G30521NA" | denotes | Gal |
| GlycanIUPAC_T59 | 648-651 | "http://rdf.glycoinfo.org/glycan/G30521NA" | denotes | Gal |
| GlycanIUPAC_T60 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G30521NA" | denotes | Gal |
| GlycanIUPAC_T61 | 392-395 | "http://rdf.glycoinfo.org/glycan/G19388CD" | denotes | Gal |
| GlycanIUPAC_T62 | 648-651 | "http://rdf.glycoinfo.org/glycan/G19388CD" | denotes | Gal |
| GlycanIUPAC_T63 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G19388CD" | denotes | Gal |
| GlycanIUPAC_T64 | 392-395 | "http://rdf.glycoinfo.org/glycan/G53151FU" | denotes | Gal |
| GlycanIUPAC_T65 | 648-651 | "http://rdf.glycoinfo.org/glycan/G53151FU" | denotes | Gal |
| GlycanIUPAC_T66 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G53151FU" | denotes | Gal |
| GlycanIUPAC_T67 | 392-395 | "http://rdf.glycoinfo.org/glycan/G27105XC" | denotes | Gal |
| GlycanIUPAC_T68 | 648-651 | "http://rdf.glycoinfo.org/glycan/G27105XC" | denotes | Gal |
| GlycanIUPAC_T69 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G27105XC" | denotes | Gal |
| GlycanIUPAC_T70 | 392-395 | "http://rdf.glycoinfo.org/glycan/G91210VM" | denotes | Gal |
| GlycanIUPAC_T71 | 648-651 | "http://rdf.glycoinfo.org/glycan/G91210VM" | denotes | Gal |
| GlycanIUPAC_T72 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G91210VM" | denotes | Gal |
| GlycanIUPAC_T73 | 392-395 | "http://rdf.glycoinfo.org/glycan/G40841DE" | denotes | Gal |
| GlycanIUPAC_T74 | 648-651 | "http://rdf.glycoinfo.org/glycan/G40841DE" | denotes | Gal |
| GlycanIUPAC_T75 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G40841DE" | denotes | Gal |
| GlycanIUPAC_T76 | 392-395 | "http://rdf.glycoinfo.org/glycan/G71241HP" | denotes | Gal |
| GlycanIUPAC_T77 | 648-651 | "http://rdf.glycoinfo.org/glycan/G71241HP" | denotes | Gal |
| GlycanIUPAC_T78 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G71241HP" | denotes | Gal |
| GlycanIUPAC_T79 | 392-395 | "http://rdf.glycoinfo.org/glycan/G84636BJ" | denotes | Gal |
| GlycanIUPAC_T80 | 648-651 | "http://rdf.glycoinfo.org/glycan/G84636BJ" | denotes | Gal |
| GlycanIUPAC_T81 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G84636BJ" | denotes | Gal |
| GlycanIUPAC_T82 | 392-395 | "http://rdf.glycoinfo.org/glycan/G47905LJ" | denotes | Gal |
| GlycanIUPAC_T83 | 648-651 | "http://rdf.glycoinfo.org/glycan/G47905LJ" | denotes | Gal |
| GlycanIUPAC_T84 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G47905LJ" | denotes | Gal |
| GlycanIUPAC_T85 | 392-395 | "http://rdf.glycoinfo.org/glycan/G39340DV" | denotes | Gal |
| GlycanIUPAC_T86 | 648-651 | "http://rdf.glycoinfo.org/glycan/G39340DV" | denotes | Gal |
| GlycanIUPAC_T87 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G39340DV" | denotes | Gal |
| GlycanIUPAC_T88 | 392-395 | "http://rdf.glycoinfo.org/glycan/G48801AQ" | denotes | Gal |
| GlycanIUPAC_T89 | 648-651 | "http://rdf.glycoinfo.org/glycan/G48801AQ" | denotes | Gal |
| GlycanIUPAC_T90 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G48801AQ" | denotes | Gal |
| GlycanIUPAC_T91 | 392-395 | "http://rdf.glycoinfo.org/glycan/G14573NX" | denotes | Gal |
| GlycanIUPAC_T92 | 648-651 | "http://rdf.glycoinfo.org/glycan/G14573NX" | denotes | Gal |
| GlycanIUPAC_T93 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G14573NX" | denotes | Gal |
| GlycanIUPAC_T94 | 392-395 | "http://rdf.glycoinfo.org/glycan/G56762TR" | denotes | Gal |
| GlycanIUPAC_T95 | 648-651 | "http://rdf.glycoinfo.org/glycan/G56762TR" | denotes | Gal |
| GlycanIUPAC_T96 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G56762TR" | denotes | Gal |
| GlycanIUPAC_T97 | 392-395 | "http://rdf.glycoinfo.org/glycan/G20013XO" | denotes | Gal |
| GlycanIUPAC_T98 | 648-651 | "http://rdf.glycoinfo.org/glycan/G20013XO" | denotes | Gal |
| GlycanIUPAC_T99 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G20013XO" | denotes | Gal |
| GlycanIUPAC_T100 | 392-395 | "http://rdf.glycoinfo.org/glycan/G39504DR" | denotes | Gal |
| GlycanIUPAC_T101 | 648-651 | "http://rdf.glycoinfo.org/glycan/G39504DR" | denotes | Gal |
| GlycanIUPAC_T102 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G39504DR" | denotes | Gal |
| GlycanIUPAC_T103 | 392-395 | "http://rdf.glycoinfo.org/glycan/G35218RQ" | denotes | Gal |
| GlycanIUPAC_T104 | 648-651 | "http://rdf.glycoinfo.org/glycan/G35218RQ" | denotes | Gal |
| GlycanIUPAC_T105 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G35218RQ" | denotes | Gal |
| GlycanIUPAC_T106 | 392-395 | "http://rdf.glycoinfo.org/glycan/G53048SH" | denotes | Gal |
| GlycanIUPAC_T107 | 648-651 | "http://rdf.glycoinfo.org/glycan/G53048SH" | denotes | Gal |
| GlycanIUPAC_T108 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G53048SH" | denotes | Gal |
| GlycanIUPAC_T109 | 392-395 | "http://rdf.glycoinfo.org/glycan/G78418IX" | denotes | Gal |
| GlycanIUPAC_T110 | 648-651 | "http://rdf.glycoinfo.org/glycan/G78418IX" | denotes | Gal |
| GlycanIUPAC_T111 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G78418IX" | denotes | Gal |
| GlycanIUPAC_T112 | 392-395 | "http://rdf.glycoinfo.org/glycan/G09780OD" | denotes | Gal |
| GlycanIUPAC_T113 | 648-651 | "http://rdf.glycoinfo.org/glycan/G09780OD" | denotes | Gal |
| GlycanIUPAC_T114 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G09780OD" | denotes | Gal |
| GlycanIUPAC_T115 | 392-395 | "http://rdf.glycoinfo.org/glycan/G56359GL" | denotes | Gal |
| GlycanIUPAC_T116 | 648-651 | "http://rdf.glycoinfo.org/glycan/G56359GL" | denotes | Gal |
| GlycanIUPAC_T117 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G56359GL" | denotes | Gal |
| GlycanIUPAC_T118 | 392-395 | "http://rdf.glycoinfo.org/glycan/G78941YC" | denotes | Gal |
| GlycanIUPAC_T119 | 648-651 | "http://rdf.glycoinfo.org/glycan/G78941YC" | denotes | Gal |
| GlycanIUPAC_T120 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G78941YC" | denotes | Gal |
| GlycanIUPAC_T121 | 392-395 | "http://rdf.glycoinfo.org/glycan/G26829FC" | denotes | Gal |
| GlycanIUPAC_T122 | 648-651 | "http://rdf.glycoinfo.org/glycan/G26829FC" | denotes | Gal |
| GlycanIUPAC_T123 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G26829FC" | denotes | Gal |
| GlycanIUPAC_T124 | 392-395 | "http://rdf.glycoinfo.org/glycan/G88538ZC" | denotes | Gal |
| GlycanIUPAC_T125 | 648-651 | "http://rdf.glycoinfo.org/glycan/G88538ZC" | denotes | Gal |
| GlycanIUPAC_T126 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G88538ZC" | denotes | Gal |
| GlycanIUPAC_T127 | 392-395 | "http://rdf.glycoinfo.org/glycan/G46593ZR" | denotes | Gal |
| GlycanIUPAC_T128 | 648-651 | "http://rdf.glycoinfo.org/glycan/G46593ZR" | denotes | Gal |
| GlycanIUPAC_T129 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G46593ZR" | denotes | Gal |
| GlycanIUPAC_T130 | 392-395 | "http://rdf.glycoinfo.org/glycan/G43523TH" | denotes | Gal |
| GlycanIUPAC_T131 | 648-651 | "http://rdf.glycoinfo.org/glycan/G43523TH" | denotes | Gal |
| GlycanIUPAC_T132 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G43523TH" | denotes | Gal |
| GlycanIUPAC_T133 | 392-395 | "http://rdf.glycoinfo.org/glycan/G36445ON" | denotes | Gal |
| GlycanIUPAC_T134 | 648-651 | "http://rdf.glycoinfo.org/glycan/G36445ON" | denotes | Gal |
| GlycanIUPAC_T135 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G36445ON" | denotes | Gal |
| GlycanIUPAC_T136 | 392-395 | "http://rdf.glycoinfo.org/glycan/G67363FK" | denotes | Gal |
| GlycanIUPAC_T137 | 648-651 | "http://rdf.glycoinfo.org/glycan/G67363FK" | denotes | Gal |
| GlycanIUPAC_T138 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G67363FK" | denotes | Gal |
| GlycanIUPAC_T139 | 392-395 | "http://rdf.glycoinfo.org/glycan/G17562KT" | denotes | Gal |
| GlycanIUPAC_T140 | 648-651 | "http://rdf.glycoinfo.org/glycan/G17562KT" | denotes | Gal |
| GlycanIUPAC_T141 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G17562KT" | denotes | Gal |
| GlycanIUPAC_T142 | 392-395 | "http://rdf.glycoinfo.org/glycan/G24774YJ" | denotes | Gal |
| GlycanIUPAC_T143 | 648-651 | "http://rdf.glycoinfo.org/glycan/G24774YJ" | denotes | Gal |
| GlycanIUPAC_T144 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G24774YJ" | denotes | Gal |
| GlycanIUPAC_T145 | 392-395 | "http://rdf.glycoinfo.org/glycan/G32162UO" | denotes | Gal |
| GlycanIUPAC_T146 | 648-651 | "http://rdf.glycoinfo.org/glycan/G32162UO" | denotes | Gal |
| GlycanIUPAC_T147 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G32162UO" | denotes | Gal |
| GlycanIUPAC_T148 | 392-395 | "http://rdf.glycoinfo.org/glycan/G89163RR" | denotes | Gal |
| GlycanIUPAC_T149 | 648-651 | "http://rdf.glycoinfo.org/glycan/G89163RR" | denotes | Gal |
| GlycanIUPAC_T150 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G89163RR" | denotes | Gal |
| GlycanIUPAC_T151 | 392-395 | "http://rdf.glycoinfo.org/glycan/G99522DY" | denotes | Gal |
| GlycanIUPAC_T152 | 648-651 | "http://rdf.glycoinfo.org/glycan/G99522DY" | denotes | Gal |
| GlycanIUPAC_T153 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G99522DY" | denotes | Gal |
| GlycanIUPAC_T154 | 392-395 | "http://rdf.glycoinfo.org/glycan/G59246IF" | denotes | Gal |
| GlycanIUPAC_T155 | 648-651 | "http://rdf.glycoinfo.org/glycan/G59246IF" | denotes | Gal |
| GlycanIUPAC_T156 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G59246IF" | denotes | Gal |
| GlycanIUPAC_T157 | 392-395 | "http://rdf.glycoinfo.org/glycan/G95321NT" | denotes | Gal |
| GlycanIUPAC_T158 | 648-651 | "http://rdf.glycoinfo.org/glycan/G95321NT" | denotes | Gal |
| GlycanIUPAC_T159 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G95321NT" | denotes | Gal |
| GlycanIUPAC_T160 | 392-395 | "http://rdf.glycoinfo.org/glycan/G17531ZI" | denotes | Gal |
| GlycanIUPAC_T161 | 648-651 | "http://rdf.glycoinfo.org/glycan/G17531ZI" | denotes | Gal |
| GlycanIUPAC_T162 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G17531ZI" | denotes | Gal |
| GlycanIUPAC_T163 | 392-395 | "http://rdf.glycoinfo.org/glycan/G54322SU" | denotes | Gal |
| GlycanIUPAC_T164 | 648-651 | "http://rdf.glycoinfo.org/glycan/G54322SU" | denotes | Gal |
| GlycanIUPAC_T165 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G54322SU" | denotes | Gal |
| GlycanIUPAC_T166 | 392-395 | "http://rdf.glycoinfo.org/glycan/G72010DO" | denotes | Gal |
| GlycanIUPAC_T167 | 648-651 | "http://rdf.glycoinfo.org/glycan/G72010DO" | denotes | Gal |
| GlycanIUPAC_T168 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G72010DO" | denotes | Gal |
| GlycanIUPAC_T169 | 392-395 | "http://rdf.glycoinfo.org/glycan/G44269EP" | denotes | Gal |
| GlycanIUPAC_T170 | 648-651 | "http://rdf.glycoinfo.org/glycan/G44269EP" | denotes | Gal |
| GlycanIUPAC_T171 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G44269EP" | denotes | Gal |
| GlycanIUPAC_T172 | 392-395 | "http://rdf.glycoinfo.org/glycan/G57335AD" | denotes | Gal |
| GlycanIUPAC_T173 | 648-651 | "http://rdf.glycoinfo.org/glycan/G57335AD" | denotes | Gal |
| GlycanIUPAC_T174 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G57335AD" | denotes | Gal |
| GlycanIUPAC_T175 | 392-395 | "http://rdf.glycoinfo.org/glycan/G60837LL" | denotes | Gal |
| GlycanIUPAC_T176 | 648-651 | "http://rdf.glycoinfo.org/glycan/G60837LL" | denotes | Gal |
| GlycanIUPAC_T177 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G60837LL" | denotes | Gal |
| GlycanIUPAC_T178 | 392-395 | "http://rdf.glycoinfo.org/glycan/G61929XX" | denotes | Gal |
| GlycanIUPAC_T179 | 648-651 | "http://rdf.glycoinfo.org/glycan/G61929XX" | denotes | Gal |
| GlycanIUPAC_T180 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G61929XX" | denotes | Gal |
| GlycanIUPAC_T181 | 392-395 | "http://rdf.glycoinfo.org/glycan/G88747RA" | denotes | Gal |
| GlycanIUPAC_T182 | 648-651 | "http://rdf.glycoinfo.org/glycan/G88747RA" | denotes | Gal |
| GlycanIUPAC_T183 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G88747RA" | denotes | Gal |
| GlycanIUPAC_T184 | 392-395 | "http://rdf.glycoinfo.org/glycan/G47955HA" | denotes | Gal |
| GlycanIUPAC_T185 | 648-651 | "http://rdf.glycoinfo.org/glycan/G47955HA" | denotes | Gal |
| GlycanIUPAC_T186 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G47955HA" | denotes | Gal |
| GlycanIUPAC_T187 | 392-395 | "http://rdf.glycoinfo.org/glycan/G60982WS" | denotes | Gal |
| GlycanIUPAC_T188 | 648-651 | "http://rdf.glycoinfo.org/glycan/G60982WS" | denotes | Gal |
| GlycanIUPAC_T189 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G60982WS" | denotes | Gal |
| GlycanIUPAC_T190 | 392-395 | "http://rdf.glycoinfo.org/glycan/G37035KG" | denotes | Gal |
| GlycanIUPAC_T191 | 648-651 | "http://rdf.glycoinfo.org/glycan/G37035KG" | denotes | Gal |
| GlycanIUPAC_T192 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G37035KG" | denotes | Gal |
| GlycanIUPAC_T193 | 392-395 | "http://rdf.glycoinfo.org/glycan/G46297FI" | denotes | Gal |
| GlycanIUPAC_T194 | 648-651 | "http://rdf.glycoinfo.org/glycan/G46297FI" | denotes | Gal |
| GlycanIUPAC_T195 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G46297FI" | denotes | Gal |
| GlycanIUPAC_T196 | 392-395 | "http://rdf.glycoinfo.org/glycan/G35475KI" | denotes | Gal |
| GlycanIUPAC_T197 | 648-651 | "http://rdf.glycoinfo.org/glycan/G35475KI" | denotes | Gal |
| GlycanIUPAC_T198 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G35475KI" | denotes | Gal |
| GlycanIUPAC_T199 | 392-395 | "http://rdf.glycoinfo.org/glycan/G29771JN" | denotes | Gal |
| GlycanIUPAC_T200 | 648-651 | "http://rdf.glycoinfo.org/glycan/G29771JN" | denotes | Gal |
| GlycanIUPAC_T201 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G29771JN" | denotes | Gal |
| GlycanIUPAC_T202 | 392-395 | "http://rdf.glycoinfo.org/glycan/G61285YR" | denotes | Gal |
| GlycanIUPAC_T203 | 648-651 | "http://rdf.glycoinfo.org/glycan/G61285YR" | denotes | Gal |
| GlycanIUPAC_T204 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G61285YR" | denotes | Gal |
| GlycanIUPAC_T205 | 392-395 | "http://rdf.glycoinfo.org/glycan/G54785MW" | denotes | Gal |
| GlycanIUPAC_T206 | 648-651 | "http://rdf.glycoinfo.org/glycan/G54785MW" | denotes | Gal |
| GlycanIUPAC_T207 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G54785MW" | denotes | Gal |
| GlycanIUPAC_T208 | 392-395 | "http://rdf.glycoinfo.org/glycan/G53039GT" | denotes | Gal |
| GlycanIUPAC_T209 | 648-651 | "http://rdf.glycoinfo.org/glycan/G53039GT" | denotes | Gal |
| GlycanIUPAC_T210 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G53039GT" | denotes | Gal |
| GlycanIUPAC_T211 | 392-395 | "http://rdf.glycoinfo.org/glycan/G00601HK" | denotes | Gal |
| GlycanIUPAC_T212 | 648-651 | "http://rdf.glycoinfo.org/glycan/G00601HK" | denotes | Gal |
| GlycanIUPAC_T213 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G00601HK" | denotes | Gal |
| GlycanIUPAC_T214 | 392-395 | "http://rdf.glycoinfo.org/glycan/G10485IJ" | denotes | Gal |
| GlycanIUPAC_T215 | 648-651 | "http://rdf.glycoinfo.org/glycan/G10485IJ" | denotes | Gal |
| GlycanIUPAC_T216 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G10485IJ" | denotes | Gal |
| GlycanIUPAC_T217 | 392-395 | "http://rdf.glycoinfo.org/glycan/G16393IB" | denotes | Gal |
| GlycanIUPAC_T218 | 648-651 | "http://rdf.glycoinfo.org/glycan/G16393IB" | denotes | Gal |
| GlycanIUPAC_T219 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G16393IB" | denotes | Gal |
| GlycanIUPAC_T220 | 392-395 | "http://rdf.glycoinfo.org/glycan/G98436FZ" | denotes | Gal |
| GlycanIUPAC_T221 | 648-651 | "http://rdf.glycoinfo.org/glycan/G98436FZ" | denotes | Gal |
| GlycanIUPAC_T222 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G98436FZ" | denotes | Gal |
| GlycanIUPAC_T223 | 392-395 | "http://rdf.glycoinfo.org/glycan/G18825IA" | denotes | Gal |
| GlycanIUPAC_T224 | 648-651 | "http://rdf.glycoinfo.org/glycan/G18825IA" | denotes | Gal |
| GlycanIUPAC_T225 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G18825IA" | denotes | Gal |
| GlycanIUPAC_T226 | 392-395 | "http://rdf.glycoinfo.org/glycan/G61281HQ" | denotes | Gal |
| GlycanIUPAC_T227 | 648-651 | "http://rdf.glycoinfo.org/glycan/G61281HQ" | denotes | Gal |
| GlycanIUPAC_T228 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G61281HQ" | denotes | Gal |
| GlycanIUPAC_T229 | 392-395 | "http://rdf.glycoinfo.org/glycan/G07798TI" | denotes | Gal |
| GlycanIUPAC_T230 | 648-651 | "http://rdf.glycoinfo.org/glycan/G07798TI" | denotes | Gal |
| GlycanIUPAC_T231 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G07798TI" | denotes | Gal |
| GlycanIUPAC_T232 | 392-395 | "http://rdf.glycoinfo.org/glycan/G55921QA" | denotes | Gal |
| GlycanIUPAC_T233 | 648-651 | "http://rdf.glycoinfo.org/glycan/G55921QA" | denotes | Gal |
| GlycanIUPAC_T234 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G55921QA" | denotes | Gal |
| GlycanIUPAC_T235 | 392-395 | "http://rdf.glycoinfo.org/glycan/G99066DL" | denotes | Gal |
| GlycanIUPAC_T236 | 648-651 | "http://rdf.glycoinfo.org/glycan/G99066DL" | denotes | Gal |
| GlycanIUPAC_T237 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G99066DL" | denotes | Gal |
| GlycanIUPAC_T238 | 392-395 | "http://rdf.glycoinfo.org/glycan/G33451PQ" | denotes | Gal |
| GlycanIUPAC_T239 | 648-651 | "http://rdf.glycoinfo.org/glycan/G33451PQ" | denotes | Gal |
| GlycanIUPAC_T240 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G33451PQ" | denotes | Gal |
| GlycanIUPAC_T241 | 392-395 | "http://rdf.glycoinfo.org/glycan/G02111XU" | denotes | Gal |
| GlycanIUPAC_T242 | 648-651 | "http://rdf.glycoinfo.org/glycan/G02111XU" | denotes | Gal |
| GlycanIUPAC_T243 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G02111XU" | denotes | Gal |
| GlycanIUPAC_T244 | 392-395 | "http://rdf.glycoinfo.org/glycan/G85193OM" | denotes | Gal |
| GlycanIUPAC_T245 | 648-651 | "http://rdf.glycoinfo.org/glycan/G85193OM" | denotes | Gal |
| GlycanIUPAC_T246 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G85193OM" | denotes | Gal |
| GlycanIUPAC_T247 | 392-395 | "http://rdf.glycoinfo.org/glycan/G89174YQ" | denotes | Gal |
| GlycanIUPAC_T248 | 648-651 | "http://rdf.glycoinfo.org/glycan/G89174YQ" | denotes | Gal |
| GlycanIUPAC_T249 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G89174YQ" | denotes | Gal |
| GlycanIUPAC_T250 | 392-395 | "http://rdf.glycoinfo.org/glycan/G28802LE" | denotes | Gal |
| GlycanIUPAC_T251 | 648-651 | "http://rdf.glycoinfo.org/glycan/G28802LE" | denotes | Gal |
| GlycanIUPAC_T252 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G28802LE" | denotes | Gal |
| GlycanIUPAC_T253 | 392-395 | "http://rdf.glycoinfo.org/glycan/G56061JK" | denotes | Gal |
| GlycanIUPAC_T254 | 648-651 | "http://rdf.glycoinfo.org/glycan/G56061JK" | denotes | Gal |
| GlycanIUPAC_T255 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G56061JK" | denotes | Gal |
| GlycanIUPAC_T256 | 392-395 | "http://rdf.glycoinfo.org/glycan/G68941BC" | denotes | Gal |
| GlycanIUPAC_T257 | 648-651 | "http://rdf.glycoinfo.org/glycan/G68941BC" | denotes | Gal |
| GlycanIUPAC_T258 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G68941BC" | denotes | Gal |
| GlycanIUPAC_T259 | 392-395 | "http://rdf.glycoinfo.org/glycan/G55436FC" | denotes | Gal |
| GlycanIUPAC_T260 | 648-651 | "http://rdf.glycoinfo.org/glycan/G55436FC" | denotes | Gal |
| GlycanIUPAC_T261 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G55436FC" | denotes | Gal |
| GlycanIUPAC_T262 | 392-395 | "http://rdf.glycoinfo.org/glycan/G24002PU" | denotes | Gal |
| GlycanIUPAC_T263 | 648-651 | "http://rdf.glycoinfo.org/glycan/G24002PU" | denotes | Gal |
| GlycanIUPAC_T264 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G24002PU" | denotes | Gal |
| GlycanIUPAC_T265 | 392-395 | "http://rdf.glycoinfo.org/glycan/G61387SV" | denotes | Gal |
| GlycanIUPAC_T266 | 648-651 | "http://rdf.glycoinfo.org/glycan/G61387SV" | denotes | Gal |
| GlycanIUPAC_T267 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G61387SV" | denotes | Gal |
| GlycanIUPAC_T268 | 392-395 | "http://rdf.glycoinfo.org/glycan/G31834HW" | denotes | Gal |
| GlycanIUPAC_T269 | 648-651 | "http://rdf.glycoinfo.org/glycan/G31834HW" | denotes | Gal |
| GlycanIUPAC_T270 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G31834HW" | denotes | Gal |
| GlycanIUPAC_T271 | 392-395 | "http://rdf.glycoinfo.org/glycan/G35324RT" | denotes | Gal |
| GlycanIUPAC_T272 | 648-651 | "http://rdf.glycoinfo.org/glycan/G35324RT" | denotes | Gal |
| GlycanIUPAC_T273 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G35324RT" | denotes | Gal |
| GlycanIUPAC_T274 | 392-395 | "http://rdf.glycoinfo.org/glycan/G34803QO" | denotes | Gal |
| GlycanIUPAC_T275 | 648-651 | "http://rdf.glycoinfo.org/glycan/G34803QO" | denotes | Gal |
| GlycanIUPAC_T276 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G34803QO" | denotes | Gal |
| GlycanIUPAC_T277 | 392-395 | "http://rdf.glycoinfo.org/glycan/G92898FF" | denotes | Gal |
| GlycanIUPAC_T278 | 648-651 | "http://rdf.glycoinfo.org/glycan/G92898FF" | denotes | Gal |
| GlycanIUPAC_T279 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G92898FF" | denotes | Gal |
| GlycanIUPAC_T280 | 392-395 | "http://rdf.glycoinfo.org/glycan/G01318VX" | denotes | Gal |
| GlycanIUPAC_T281 | 648-651 | "http://rdf.glycoinfo.org/glycan/G01318VX" | denotes | Gal |
| GlycanIUPAC_T282 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G01318VX" | denotes | Gal |
| GlycanIUPAC_T283 | 392-395 | "http://rdf.glycoinfo.org/glycan/G83200MX" | denotes | Gal |
| GlycanIUPAC_T284 | 648-651 | "http://rdf.glycoinfo.org/glycan/G83200MX" | denotes | Gal |
| GlycanIUPAC_T285 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G83200MX" | denotes | Gal |
| GlycanIUPAC_T286 | 392-395 | "http://rdf.glycoinfo.org/glycan/G56286UC" | denotes | Gal |
| GlycanIUPAC_T287 | 648-651 | "http://rdf.glycoinfo.org/glycan/G56286UC" | denotes | Gal |
| GlycanIUPAC_T288 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G56286UC" | denotes | Gal |
| GlycanIUPAC_T289 | 392-395 | "http://rdf.glycoinfo.org/glycan/G07304QA" | denotes | Gal |
| GlycanIUPAC_T290 | 648-651 | "http://rdf.glycoinfo.org/glycan/G07304QA" | denotes | Gal |
| GlycanIUPAC_T291 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G07304QA" | denotes | Gal |
| GlycanIUPAC_T292 | 392-395 | "http://rdf.glycoinfo.org/glycan/G06868OU" | denotes | Gal |
| GlycanIUPAC_T293 | 648-651 | "http://rdf.glycoinfo.org/glycan/G06868OU" | denotes | Gal |
| GlycanIUPAC_T294 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G06868OU" | denotes | Gal |
| GlycanIUPAC_T295 | 392-395 | "http://rdf.glycoinfo.org/glycan/G12647BS" | denotes | Gal |
| GlycanIUPAC_T296 | 648-651 | "http://rdf.glycoinfo.org/glycan/G12647BS" | denotes | Gal |
| GlycanIUPAC_T297 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G12647BS" | denotes | Gal |
| GlycanIUPAC_T298 | 392-395 | "http://rdf.glycoinfo.org/glycan/G51841DF" | denotes | Gal |
| GlycanIUPAC_T299 | 648-651 | "http://rdf.glycoinfo.org/glycan/G51841DF" | denotes | Gal |
| GlycanIUPAC_T300 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G51841DF" | denotes | Gal |
| GlycanIUPAC_T301 | 392-395 | "http://rdf.glycoinfo.org/glycan/G32122AJ" | denotes | Gal |
| GlycanIUPAC_T302 | 648-651 | "http://rdf.glycoinfo.org/glycan/G32122AJ" | denotes | Gal |
| GlycanIUPAC_T303 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G32122AJ" | denotes | Gal |
| GlycanIUPAC_T304 | 392-395 | "http://rdf.glycoinfo.org/glycan/G41125MN" | denotes | Gal |
| GlycanIUPAC_T305 | 648-651 | "http://rdf.glycoinfo.org/glycan/G41125MN" | denotes | Gal |
| GlycanIUPAC_T306 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G41125MN" | denotes | Gal |
| GlycanIUPAC_T307 | 392-395 | "http://rdf.glycoinfo.org/glycan/G16093XS" | denotes | Gal |
| GlycanIUPAC_T308 | 648-651 | "http://rdf.glycoinfo.org/glycan/G16093XS" | denotes | Gal |
| GlycanIUPAC_T309 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G16093XS" | denotes | Gal |
| GlycanIUPAC_T310 | 392-395 | "http://rdf.glycoinfo.org/glycan/G62425IX" | denotes | Gal |
| GlycanIUPAC_T311 | 648-651 | "http://rdf.glycoinfo.org/glycan/G62425IX" | denotes | Gal |
| GlycanIUPAC_T312 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G62425IX" | denotes | Gal |
| GlycanIUPAC_T313 | 392-395 | "http://rdf.glycoinfo.org/glycan/G15673TO" | denotes | Gal |
| GlycanIUPAC_T314 | 648-651 | "http://rdf.glycoinfo.org/glycan/G15673TO" | denotes | Gal |
| GlycanIUPAC_T315 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G15673TO" | denotes | Gal |
| GlycanIUPAC_T316 | 392-395 | "http://rdf.glycoinfo.org/glycan/G32857IK" | denotes | Gal |
| GlycanIUPAC_T317 | 648-651 | "http://rdf.glycoinfo.org/glycan/G32857IK" | denotes | Gal |
| GlycanIUPAC_T318 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G32857IK" | denotes | Gal |
| GlycanIUPAC_T319 | 392-395 | "http://rdf.glycoinfo.org/glycan/G60047CJ" | denotes | Gal |
| GlycanIUPAC_T320 | 648-651 | "http://rdf.glycoinfo.org/glycan/G60047CJ" | denotes | Gal |
| GlycanIUPAC_T321 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G60047CJ" | denotes | Gal |
| GlycanIUPAC_T322 | 392-395 | "http://rdf.glycoinfo.org/glycan/G55718ZB" | denotes | Gal |
| GlycanIUPAC_T323 | 648-651 | "http://rdf.glycoinfo.org/glycan/G55718ZB" | denotes | Gal |
| GlycanIUPAC_T324 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G55718ZB" | denotes | Gal |
| GlycanIUPAC_T325 | 392-395 | "http://rdf.glycoinfo.org/glycan/G88355ZE" | denotes | Gal |
| GlycanIUPAC_T326 | 648-651 | "http://rdf.glycoinfo.org/glycan/G88355ZE" | denotes | Gal |
| GlycanIUPAC_T327 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G88355ZE" | denotes | Gal |
| GlycanIUPAC_T328 | 392-395 | "http://rdf.glycoinfo.org/glycan/G11283PA" | denotes | Gal |
| GlycanIUPAC_T329 | 648-651 | "http://rdf.glycoinfo.org/glycan/G11283PA" | denotes | Gal |
| GlycanIUPAC_T330 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G11283PA" | denotes | Gal |
| GlycanIUPAC_T331 | 392-395 | "http://rdf.glycoinfo.org/glycan/G71737IZ" | denotes | Gal |
| GlycanIUPAC_T332 | 648-651 | "http://rdf.glycoinfo.org/glycan/G71737IZ" | denotes | Gal |
| GlycanIUPAC_T333 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G71737IZ" | denotes | Gal |
| GlycanIUPAC_T334 | 392-395 | "http://rdf.glycoinfo.org/glycan/G60912WZ" | denotes | Gal |
| GlycanIUPAC_T335 | 648-651 | "http://rdf.glycoinfo.org/glycan/G60912WZ" | denotes | Gal |
| GlycanIUPAC_T336 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G60912WZ" | denotes | Gal |
| GlycanIUPAC_T337 | 392-395 | "http://rdf.glycoinfo.org/glycan/G99655SO" | denotes | Gal |
| GlycanIUPAC_T338 | 648-651 | "http://rdf.glycoinfo.org/glycan/G99655SO" | denotes | Gal |
| GlycanIUPAC_T339 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G99655SO" | denotes | Gal |
| GlycanIUPAC_T340 | 392-395 | "http://rdf.glycoinfo.org/glycan/G10300TW" | denotes | Gal |
| GlycanIUPAC_T341 | 648-651 | "http://rdf.glycoinfo.org/glycan/G10300TW" | denotes | Gal |
| GlycanIUPAC_T342 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G10300TW" | denotes | Gal |
| GlycanIUPAC_T343 | 392-395 | "http://rdf.glycoinfo.org/glycan/G89509FL" | denotes | Gal |
| GlycanIUPAC_T344 | 648-651 | "http://rdf.glycoinfo.org/glycan/G89509FL" | denotes | Gal |
| GlycanIUPAC_T345 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G89509FL" | denotes | Gal |
| GlycanIUPAC_T346 | 392-395 | "http://rdf.glycoinfo.org/glycan/G31465TH" | denotes | Gal |
| GlycanIUPAC_T347 | 648-651 | "http://rdf.glycoinfo.org/glycan/G31465TH" | denotes | Gal |
| GlycanIUPAC_T348 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G31465TH" | denotes | Gal |
| GlycanIUPAC_T349 | 392-395 | "http://rdf.glycoinfo.org/glycan/G94101LU" | denotes | Gal |
| GlycanIUPAC_T350 | 648-651 | "http://rdf.glycoinfo.org/glycan/G94101LU" | denotes | Gal |
| GlycanIUPAC_T351 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G94101LU" | denotes | Gal |
| GlycanIUPAC_T352 | 392-395 | "http://rdf.glycoinfo.org/glycan/G38610BB" | denotes | Gal |
| GlycanIUPAC_T353 | 648-651 | "http://rdf.glycoinfo.org/glycan/G38610BB" | denotes | Gal |
| GlycanIUPAC_T354 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G38610BB" | denotes | Gal |
| GlycanIUPAC_T355 | 392-395 | "http://rdf.glycoinfo.org/glycan/G85893UF" | denotes | Gal |
| GlycanIUPAC_T356 | 648-651 | "http://rdf.glycoinfo.org/glycan/G85893UF" | denotes | Gal |
| GlycanIUPAC_T357 | 2010-2013 | "http://rdf.glycoinfo.org/glycan/G85893UF" | denotes | Gal |
| GlycanIUPAC_T358 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G26693XF" | denotes | GlcNAc |
| GlycanIUPAC_T359 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G01864SU" | denotes | GlcNAc |
| GlycanIUPAC_T360 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G17605FD" | denotes | GlcNAc |
| GlycanIUPAC_T361 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G41950LU" | denotes | GlcNAc |
| GlycanIUPAC_T362 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G57195RJ" | denotes | GlcNAc |
| GlycanIUPAC_T363 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G85391SA" | denotes | GlcNAc |
| GlycanIUPAC_T364 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G89565QL" | denotes | GlcNAc |
| GlycanIUPAC_T365 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G80869MR" | denotes | GlcNAc |
| GlycanIUPAC_T366 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G55978NL" | denotes | GlcNAc |
| GlycanIUPAC_T367 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G54644LT" | denotes | GlcNAc |
| GlycanIUPAC_T368 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G25694UG" | denotes | GlcNAc |
| GlycanIUPAC_T369 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G25126RB" | denotes | GlcNAc |
| GlycanIUPAC_T370 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G51848AD" | denotes | GlcNAc |
| GlycanIUPAC_T371 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G94667GM" | denotes | GlcNAc |
| GlycanIUPAC_T372 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G30124BO" | denotes | GlcNAc |
| GlycanIUPAC_T373 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G82777EZ" | denotes | GlcNAc |
| GlycanIUPAC_T374 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G10151YZ" | denotes | GlcNAc |
| GlycanIUPAC_T375 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G17585ZM" | denotes | GlcNAc |
| GlycanIUPAC_T376 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G04411CJ" | denotes | GlcNAc |
| GlycanIUPAC_T377 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G38254HJ" | denotes | GlcNAc |
| GlycanIUPAC_T378 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G75188FS" | denotes | GlcNAc |
| GlycanIUPAC_T379 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G70374VG" | denotes | GlcNAc |
| GlycanIUPAC_T380 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G45176LJ" | denotes | GlcNAc |
| GlycanIUPAC_T381 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G30874VW" | denotes | GlcNAc |
| GlycanIUPAC_T382 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G69333MI" | denotes | GlcNAc |
| GlycanIUPAC_T383 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G10676XO" | denotes | GlcNAc |
| GlycanIUPAC_T384 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G14843DJ" | denotes | GlcNAc |
| GlycanIUPAC_T385 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G47546FR" | denotes | GlcNAc |
| GlycanIUPAC_T386 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G73695ZM" | denotes | GlcNAc |
| GlycanIUPAC_T387 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G31923TJ" | denotes | GlcNAc |
| GlycanIUPAC_T388 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G60519EP" | denotes | GlcNAc |
| GlycanIUPAC_T389 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G07933IA" | denotes | GlcNAc |
| GlycanIUPAC_T390 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G40745NH" | denotes | GlcNAc |
| GlycanIUPAC_T391 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G54496YV" | denotes | GlcNAc |
| GlycanIUPAC_T392 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G62953SQ" | denotes | GlcNAc |
| GlycanIUPAC_T393 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G70070AY" | denotes | GlcNAc |
| GlycanIUPAC_T394 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G78792WC" | denotes | GlcNAc |
| GlycanIUPAC_T395 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G25238AV" | denotes | GlcNAc |
| GlycanIUPAC_T396 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G40510DP" | denotes | GlcNAc |
| GlycanIUPAC_T397 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G61120TK" | denotes | GlcNAc |
| GlycanIUPAC_T398 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G41342KV" | denotes | GlcNAc |
| GlycanIUPAC_T399 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G90703NA" | denotes | GlcNAc |
| GlycanIUPAC_T400 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G01591HR" | denotes | GlcNAc |
| GlycanIUPAC_T401 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G56520XN" | denotes | GlcNAc |
| GlycanIUPAC_T402 | 1354-1360 | "http://rdf.glycoinfo.org/glycan/G81830JX" | denotes | GlcNAc |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 170-177 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colonic |
| PD-UBERON-AE-B_T2 | 1203-1210 | http://purl.obolibrary.org/obo/UBERON_0001155 | denotes | colonic |
| PD-UBERON-AE-B_T3 | 2093-2102 | http://purl.obolibrary.org/obo/UBERON_2000106 | denotes | extension |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 170-187 | Disease | denotes | colonic carcinoma | http://purl.obolibrary.org/obo/MONDO_0002032 |
| T2 | 1203-1220 | Disease | denotes | colonic carcinoma | http://purl.obolibrary.org/obo/MONDO_0002032 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 440-447 | Glycan | denotes | Lewis A | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39023AU |
| T2 | 452-466 | Glycan | denotes | sialyl Lewis A | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO |
GlyCosmos15-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 178-187 | Phenotype | denotes | carcinoma | HP:0030731 |
| T2 | 1211-1220 | Phenotype | denotes | carcinoma | HP:0030731 |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 170-187 | Disease | denotes | colonic carcinoma | http://purl.obolibrary.org/obo/MONDO_0002032 |
| T2 | 1203-1220 | Disease | denotes | colonic carcinoma | http://purl.obolibrary.org/obo/MONDO_0002032 |
GlyCosmos15-NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 164-169 | OrganismTaxon | denotes | human | 9606 |
GlyCosmos15-CL
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 764-768 | Cell | denotes | poly | http://purl.obolibrary.org/obo/CL:0000096|http://purl.obolibrary.org/obo/CL:0000775 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 2093-2102 | Body_part | denotes | extension | http://purl.obolibrary.org/obo/UBERON_2000106 |
GlyCosmos15-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 170-177 | Body_part | denotes | colonic | http://purl.obolibrary.org/obo/MAT_0000526 |
| T2 | 1203-1210 | Body_part | denotes | colonic | http://purl.obolibrary.org/obo/MAT_0000526 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-199 | Sentence | denotes | Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines. |
| TextSentencer_T2 | 200-542 | Sentence | denotes | In general, an elevated expression of beta 3-galactosyltransferase (beta 3GalT) activity contributed by beta 3GalT5 correlates well with increased biosynthesis and expression of type 1 chain (Gal beta 1-3GlcNAc beta 1-) derivatives such as Lewis A and sialyl Lewis A, which are mostly recognized as terminal epitopes and not further extended. |
| TextSentencer_T3 | 543-796 | Sentence | denotes | Most known beta 3-N-acetylglucosaminyltransferases show a higher activity toward extending type 2 chain (Gal beta 1-4GlcNAc beta 1-), and an over-expression of beta 3GalT5 could suppress the formation of the type 2 chain poly-N-acetyllactosaminoglycans. |
| TextSentencer_T4 | 797-1029 | Sentence | denotes | The potential of extending instead the predominant type 1 chain termini synthesized under such circumstances was, however, not investigated, partly due to technical difficulty in unambiguous identification of extended type 1 chains. |
| TextSentencer_T5 | 1030-1472 | Sentence | denotes | Using an advanced mass spectrometry-based glycomic mapping and glycan sequencing approach, we show here that type 1 chains carried on the lacto-series glycosphingolipids of colonic carcinoma cells can be extended when the endogenous beta 3GalT activity relative to competing beta 4GalT activity, as defined against a common GlcNAc beta 1-3Gal beta 1-4Glc acceptor, is sufficiently high, as found in Colo205 and SW1116, but not in DLD-1 cells. |
| TextSentencer_T6 | 1473-1805 | Sentence | denotes | In support of this positive correlation, the lacto-series glycosphingolipids isolated from stably transfected DLD-1 clones over-expressing beta 3GalT5 were shown to comprise fucosylated dimeric type 1 chains, whereas a mock transfectant and the DLD-1 parent carried only fucosylated dimeric type 2 chains on their lactosylceramides. |
| TextSentencer_T7 | 1806-2227 | Sentence | denotes | It suggests that while the natural expression of extended type 1 chain is likely to be determined by many contributing factors including the relative amounts of competing glycosyltransferases and the UDP-Gal level, the enhanced expression of beta 3GalT5 is sufficient to promote in vivo extension of type 1 chains by furnishing a significantly higher amount of type 1 chain precursors relative to competing type 2 chains. |
| T1 | 0-199 | Sentence | denotes | Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines. |
| T2 | 200-542 | Sentence | denotes | In general, an elevated expression of beta 3-galactosyltransferase (beta 3GalT) activity contributed by beta 3GalT5 correlates well with increased biosynthesis and expression of type 1 chain (Gal beta 1-3GlcNAc beta 1-) derivatives such as Lewis A and sialyl Lewis A, which are mostly recognized as terminal epitopes and not further extended. |
| T3 | 543-796 | Sentence | denotes | Most known beta 3-N-acetylglucosaminyltransferases show a higher activity toward extending type 2 chain (Gal beta 1-4GlcNAc beta 1-), and an over-expression of beta 3GalT5 could suppress the formation of the type 2 chain poly-N-acetyllactosaminoglycans. |
| T4 | 797-1029 | Sentence | denotes | The potential of extending instead the predominant type 1 chain termini synthesized under such circumstances was, however, not investigated, partly due to technical difficulty in unambiguous identification of extended type 1 chains. |
| T5 | 1030-1472 | Sentence | denotes | Using an advanced mass spectrometry-based glycomic mapping and glycan sequencing approach, we show here that type 1 chains carried on the lacto-series glycosphingolipids of colonic carcinoma cells can be extended when the endogenous beta 3GalT activity relative to competing beta 4GalT activity, as defined against a common GlcNAc beta 1-3Gal beta 1-4Glc acceptor, is sufficiently high, as found in Colo205 and SW1116, but not in DLD-1 cells. |
| T6 | 1473-1805 | Sentence | denotes | In support of this positive correlation, the lacto-series glycosphingolipids isolated from stably transfected DLD-1 clones over-expressing beta 3GalT5 were shown to comprise fucosylated dimeric type 1 chains, whereas a mock transfectant and the DLD-1 parent carried only fucosylated dimeric type 2 chains on their lactosylceramides. |
| T7 | 1806-2227 | Sentence | denotes | It suggests that while the natural expression of extended type 1 chain is likely to be determined by many contributing factors including the relative amounts of competing glycosyltransferases and the UDP-Gal level, the enhanced expression of beta 3GalT5 is sufficient to promote in vivo extension of type 1 chains by furnishing a significantly higher amount of type 1 chain precursors relative to competing type 2 chains. |
| T1 | 0-199 | Sentence | denotes | Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines. |
| T2 | 200-542 | Sentence | denotes | In general, an elevated expression of beta 3-galactosyltransferase (beta 3GalT) activity contributed by beta 3GalT5 correlates well with increased biosynthesis and expression of type 1 chain (Gal beta 1-3GlcNAc beta 1-) derivatives such as Lewis A and sialyl Lewis A, which are mostly recognized as terminal epitopes and not further extended. |
| T3 | 543-796 | Sentence | denotes | Most known beta 3-N-acetylglucosaminyltransferases show a higher activity toward extending type 2 chain (Gal beta 1-4GlcNAc beta 1-), and an over-expression of beta 3GalT5 could suppress the formation of the type 2 chain poly-N-acetyllactosaminoglycans. |
| T4 | 797-1029 | Sentence | denotes | The potential of extending instead the predominant type 1 chain termini synthesized under such circumstances was, however, not investigated, partly due to technical difficulty in unambiguous identification of extended type 1 chains. |
| T5 | 1030-1472 | Sentence | denotes | Using an advanced mass spectrometry-based glycomic mapping and glycan sequencing approach, we show here that type 1 chains carried on the lacto-series glycosphingolipids of colonic carcinoma cells can be extended when the endogenous beta 3GalT activity relative to competing beta 4GalT activity, as defined against a common GlcNAc beta 1-3Gal beta 1-4Glc acceptor, is sufficiently high, as found in Colo205 and SW1116, but not in DLD-1 cells. |
| T6 | 1473-1805 | Sentence | denotes | In support of this positive correlation, the lacto-series glycosphingolipids isolated from stably transfected DLD-1 clones over-expressing beta 3GalT5 were shown to comprise fucosylated dimeric type 1 chains, whereas a mock transfectant and the DLD-1 parent carried only fucosylated dimeric type 2 chains on their lactosylceramides. |
| T7 | 1806-2227 | Sentence | denotes | It suggests that while the natural expression of extended type 1 chain is likely to be determined by many contributing factors including the relative amounts of competing glycosyltransferases and the UDP-Gal level, the enhanced expression of beta 3GalT5 is sufficient to promote in vivo extension of type 1 chains by furnishing a significantly higher amount of type 1 chain precursors relative to competing type 2 chains. |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-199 | Sentence | denotes | Enhanced expression of beta 3-galactosyltransferase 5 activity is sufficient to induce in vivo synthesis of extended type 1 chains on lactosylceramides of selected human colonic carcinoma cell lines. |
| T2 | 200-542 | Sentence | denotes | In general, an elevated expression of beta 3-galactosyltransferase (beta 3GalT) activity contributed by beta 3GalT5 correlates well with increased biosynthesis and expression of type 1 chain (Gal beta 1-3GlcNAc beta 1-) derivatives such as Lewis A and sialyl Lewis A, which are mostly recognized as terminal epitopes and not further extended. |
| T3 | 543-796 | Sentence | denotes | Most known beta 3-N-acetylglucosaminyltransferases show a higher activity toward extending type 2 chain (Gal beta 1-4GlcNAc beta 1-), and an over-expression of beta 3GalT5 could suppress the formation of the type 2 chain poly-N-acetyllactosaminoglycans. |
| T4 | 797-1029 | Sentence | denotes | The potential of extending instead the predominant type 1 chain termini synthesized under such circumstances was, however, not investigated, partly due to technical difficulty in unambiguous identification of extended type 1 chains. |
| T5 | 1030-1472 | Sentence | denotes | Using an advanced mass spectrometry-based glycomic mapping and glycan sequencing approach, we show here that type 1 chains carried on the lacto-series glycosphingolipids of colonic carcinoma cells can be extended when the endogenous beta 3GalT activity relative to competing beta 4GalT activity, as defined against a common GlcNAc beta 1-3Gal beta 1-4Glc acceptor, is sufficiently high, as found in Colo205 and SW1116, but not in DLD-1 cells. |
| T6 | 1473-1805 | Sentence | denotes | In support of this positive correlation, the lacto-series glycosphingolipids isolated from stably transfected DLD-1 clones over-expressing beta 3GalT5 were shown to comprise fucosylated dimeric type 1 chains, whereas a mock transfectant and the DLD-1 parent carried only fucosylated dimeric type 2 chains on their lactosylceramides. |
| T7 | 1806-2227 | Sentence | denotes | It suggests that while the natural expression of extended type 1 chain is likely to be determined by many contributing factors including the relative amounts of competing glycosyltransferases and the UDP-Gal level, the enhanced expression of beta 3GalT5 is sufficient to promote in vivo extension of type 1 chains by furnishing a significantly higher amount of type 1 chain precursors relative to competing type 2 chains. |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 440-447 | Glycan | denotes | Lewis A | https://api.glycosmos.org/wurcs2image/latest/png/binary/G39023AU |
| T2 | 452-466 | Glycan | denotes | sialyl Lewis A | https://api.glycosmos.org/wurcs2image/latest/png/binary/G00053MO |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 134-151 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | lactosylceramides | http://www.glycoepitope.jp/epitopes/EP0078 |
| T2 | 440-447 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Lewis A | http://www.glycoepitope.jp/epitopes/EP0007 |
| T3 | 452-466 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | sialyl Lewis A | http://www.glycoepitope.jp/epitopes/EP0008 |
| T4 | 1787-1804 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | lactosylceramides | http://www.glycoepitope.jp/epitopes/EP0078 |
NCBITAXON
| Id | Subject | Object | Predicate | Lexical cue | db_id |
|---|---|---|---|---|---|
| T1 | 164-169 | OrganismTaxon | denotes | human | 9606 |
GlyCosmos-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 134-151 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | lactosylceramides | http://www.glycoepitope.jp/epitopes/EP0078 |
| T2 | 440-447 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | Lewis A | http://www.glycoepitope.jp/epitopes/EP0007 |
| T3 | 452-466 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | sialyl Lewis A | http://www.glycoepitope.jp/epitopes/EP0008 |
| T4 | 1787-1804 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | lactosylceramides | http://www.glycoepitope.jp/epitopes/EP0078 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 2093-2102 | Body_part | denotes | extension | http://purl.obolibrary.org/obo/UBERON_2000106 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 170-177 | Body_part | denotes | colonic | http://purl.obolibrary.org/obo/MAT_0000526 |
| T2 | 1203-1210 | Body_part | denotes | colonic | http://purl.obolibrary.org/obo/MAT_0000526 |
HP-phenotype
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T1 | 178-187 | Phenotype | denotes | carcinoma | HP:0030731 |
| T2 | 1211-1220 | Phenotype | denotes | carcinoma | HP:0030731 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 764-768 | Cell | denotes | poly | http://purl.obolibrary.org/obo/CL:0000096|http://purl.obolibrary.org/obo/CL:0000775 |